Biotechnology is the broad field concerned with using living organisms, cells, biological systems, biological molecules, or biological processes to develop products, processes, services, and technologies. Its modern scope spans molecular biology, microbiology, genetics, biochemistry, cell biology, engineering, medicine, agriculture, food production, industrial manufacturing, environmental management, and increasingly computational science. The term is commonly used for both traditional biological production and highly engineered modern applications, although contemporary usage often emphasises technologies that deliberately manipulate or exploit biological mechanisms.
Fermentation for producing bread, cheese, beer, and organic acids represents ancient biotechnology, whereas recombinant DNA production, monoclonal antibodies, engineered microbes, cultured cells, and gene therapies represent modern biotechnology. Biotechnology therefore describes an application-oriented technological domain rather than a single technique or scientific discipline. Its defining feature is the purposeful conversion of biological knowledge into practical capability, whether that capability involves producing a molecule, modifying an organism, diagnosing disease, manufacturing a material, processing waste, or manipulating biological information.
The historical development of biotechnology predates the scientific understanding of heredity or microorganisms by thousands of years. Domestication and selective breeding changed plants and animals according to desired traits, while fermentation processes exploited microorganisms without knowing that microorganisms were responsible. The nineteenth century brought increasingly systematic understanding through microbiology, including work associated with Louis Pasteur, and genetics subsequently provided an explanatory framework for inheritance.
The twentieth century introduced industrial microbiology, tissue culture, antibiotics, enzyme technology, molecular biology, recombinant DNA, and monoclonal antibody technology. A major transition occurred after the discovery of DNA's molecular structure and the development of methods for isolating, cutting, joining, copying, and expressing DNA. Recombinant DNA technology enabled genes to be transferred between biological systems and expressed in host organisms. Subsequent advances in DNA sequencing, polymerase chain reaction, genomics, proteomics, computational biology, synthetic biology, gene editing, and high-throughput screening progressively transformed biotechnology from primarily organism-level manipulation into a highly programmable molecular technology platform.
Biotechnology is commonly divided into application areas according to the biological systems and problems being addressed. Medical and pharmaceutical biotechnology includes vaccines, recombinant proteins, antibodies, cell therapies, gene therapies, molecular diagnostics, and biologically derived medicines. Agricultural biotechnology includes genetically modified crops, molecular breeding, biological pest control, improved nutritional characteristics, and traits associated with drought, disease, or environmental stress.
Industrial biotechnology uses microorganisms, enzymes, and engineered metabolic pathways to manufacture chemicals, fuels, materials, food ingredients, and other products, often through fermentation or biocatalysis. Environmental biotechnology applies biological systems to wastewater treatment, bioremediation, pollutant degradation, resource recovery, and environmental monitoring. Food biotechnology encompasses fermentation, enzymes, microbial cultures, food preservation, and newer approaches such as precision fermentation. Marine biotechnology investigates organisms and molecules from aquatic environments. Each area uses different combinations of molecular biology, microbiology, engineering, analytical chemistry, computational methods, and process optimisation.
A central characteristic of biotechnology is the ability to exploit biological specificity. Enzymes can catalyse particular chemical reactions under comparatively mild conditions, antibodies can recognise molecular targets with high selectivity, microorganisms can convert inexpensive substrates into valuable products, and cells can synthesise complex molecules that may be difficult to manufacture chemically. Biotechnology also depends heavily on biological systems being highly interconnected, which creates both opportunities and engineering constraints.
Changing one gene can affect multiple cellular pathways, metabolic flux can be redistributed by pathway engineering, and cellular growth can compete with product formation for limited resources. Industrial biotechnology consequently requires more than designing a biological mechanism: strains or cell lines must often be developed for stability, productivity, tolerance to process conditions, and reproducible performance. Bioprocess engineering connects laboratory biology with scalable production through fermentation, cell culture, downstream purification, formulation, quality control, and process monitoring. The practical value of a biotechnology is therefore determined not only by biological function but also by manufacturability, reliability, cost, regulation, and scalability.
Modern biotechnology increasingly operates as an integrated experimental and computational discipline. DNA sequencing can reveal genetic variation, transcriptomics can measure RNA expression, proteomics can characterise proteins, metabolomics can measure small molecules, and bioinformatics can integrate these datasets to identify biological relationships. Genetic engineering can then alter selected genes or pathways, while screening and measurement determine whether the modification produces the desired phenotype.
Synthetic biology extends this engineering approach by treating biological components and genetic circuits as designable systems, although biological systems remain substantially more context-dependent than conventional engineered components. Automation, robotics, high-throughput experimentation, machine learning, laboratory information systems, and computational modelling increasingly allow large numbers of biological designs to be generated and evaluated. This creates iterative design-build-test-learn workflows in which computational predictions inform biological construction, experimental results refine models, and improved models guide subsequent experiments.
Biotechnology has significant practical advantages but also important limitations. Biological production can provide high molecular specificity, renewable feedstocks, catalytic efficiency, self-replication of biological production systems, and access to complex molecules that are difficult to synthesise conventionally. However, living systems can be sensitive to temperature, pH, nutrient availability, contamination, genetic instability, metabolic burden, and process variation.
A laboratory result may not translate directly to industrial scale because oxygen transfer, heat removal, mixing, substrate gradients, and other physical parameters change with reactor size. Biological products can also require demanding purification and quality-control procedures. In medicine, additional challenges include immunogenicity, delivery, off-target biological effects, manufacturing consistency, and long-term safety. Agricultural and environmental applications may involve ecological considerations that differ from those of contained industrial processes. Biotechnology therefore requires multidisciplinary assessment encompassing biological performance, engineering feasibility, economics, safety, environmental impact, intellectual property, and applicable regulatory requirements.
The field is closely connected to several related but distinct concepts. Genetic engineering specifically concerns deliberate modification of genetic material, whereas biotechnology encompasses genetic engineering but is substantially broader. Molecular biology seeks to understand biological mechanisms at the molecular level and supplies much of the knowledge used by biotechnology, but understanding a mechanism is not itself necessarily a technological application.
Synthetic biology emphasises deliberate design and construction of biological systems, while biotechnology may use naturally occurring biological systems without redesigning them. Bioinformatics and computational biology provide computational methods for analysing biological information and modelling biological systems, but do not necessarily produce a physical biotechnology product. Bioprocess engineering addresses the scalable cultivation, production, recovery, and purification of biological products. Biotechnology also overlaps with pharmaceutical science, chemical engineering, materials science, environmental science, and agriculture. These distinctions matter because biotechnology is best understood as a large technological ecosystem incorporating many scientific disciplines rather than as a synonym for genetic modification or gene editing.
Biotechnology has become strategically important because biological systems can serve simultaneously as sources of information, catalysts, manufacturing platforms, therapeutic agents, and engineered production systems. Recombinant insulin demonstrated that microorganisms could be used to manufacture medically important human proteins; monoclonal antibodies established cell-based manufacturing as a major pharmaceutical platform; engineered microbes have enabled production of chemicals and ingredients; and cell and gene therapies have expanded the role of biotechnology from manufacturing molecules to modifying or replacing biological functions in patients.
Current development increasingly involves combining biological engineering with genomic analysis, automation, artificial intelligence, advanced sequencing, and precise genetic manipulation. At the same time, biotechnology raises questions involving biosafety, biosecurity, environmental release, ownership of biological inventions, clinical evidence, equitable access, and governance. Its significance therefore extends beyond individual products: biotechnology represents a technological framework for deliberately harnessing biological processes, with applications ranging from established industrial fermentation to increasingly sophisticated manipulation of cells, genomes, and biological information.
